Close Menu

The Scan

Secret No More

If you've been funded by a pharma, it may be time for the world to find out.

How much weight should academic degrees be given in the hiring process? The Omics! Omics! blogger takes a stand.

The Guardian explores the impact of "pharming" genetically modified plants.

New software quantifies scientists’ citations using Google Scholar.

The University of Miami has been hiring genomic scientists by the truckload.

Harvard's Gary Ruvkun is looking for DNA ... on Mars.

This Wired News article talks about a proposed Gut Genome Project to explore normal bacteria presence in humans.

GTO scans today's issue of Science.

A Forbes article delves into why so many people just can't stand networking.

Today in Nature

Today's Nature roundup.

A blogger picks his authorship battles.

A new approach to learning bioethics--on the internet.

In Honor of DNA Day

High-schoolers from Michigan and Maryland win ASHG essay contest.

Darwin Does Chicago

A new exhibit on Darwin opens at Chicago's Field Museum in June.

A blogger discusses how to analyze RNAi data.

Nathan Wolfe spends his days looking for the next great viral epidemic.

A group at Stanford and UCSC posit a non-junk role for lots of junk DNA.

At least one oddsmaker is already encouraging bets on who will win a Nobel Prize this fall.

They live on, around, and within us. Isn't it time we got to know our microbial neighbors?

Susan Lindquist sits down for a chat with the New York Times.

Nancy Wexler wins an award from the Franklin Institute in Philadelphia.

ChIP-chip studies on Arabidopsis reveal a primary gene silencing mechanism.

Not only do genomes make up organisms, but they also make pretty quilts.

The Wall Street Journal looks into plans to provide coverage for 45 million people in the US who lack health insurance.

A new study questions the benefits of using volunteers for clinical trials.


In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.